Related Experiment Video
Updated: Aug 16, 2026
12:55
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
Genetic strategies for brain tumor therapy
S E Lawler1, P P Peruzzi, E A Chiocca
1Department of Neurological Surgery, The Dardinger Family Laboratory for Neuro-oncology and Neurosciences, The Ohio State University Medical Center, Columbus, 43210, USA.
Cancer Gene Therapy
|September 3, 2005
Summary
Gene therapy offers potential for brain tumor treatment, but clinical trials face challenges. Advances in viral vectors and stem cell technology may improve future gene therapy efficacy for brain cancers.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Biotechnology
Background:
- Human brain tumors are highly resistant to conventional treatments.
- Current clinical trials for gene therapy in brain tumors have shown limited success in improving patient outcomes.
- Significant challenges remain in developing effective gene therapy strategies for brain malignancies.
Purpose of the Study:
- To review the current status and future prospects of gene therapy for human brain tumors.
- To highlight recent advancements that could enhance the efficacy of gene-based treatments.
- To provide a hopeful outlook on the next generation of gene therapeutics for brain cancer.
Main Methods:
- Review of existing literature on gene therapy for brain tumors.
- Analysis of recent progress in viral vector technology.
- Evaluation of developments in stem cell technology for therapeutic delivery.
- Examination of the understanding of therapeutic transgene mechanisms.
Main Results:
- Despite past clinical trial limitations, gene therapy remains a promising avenue for brain tumor treatment.
- Improvements in viral vectors offer enhanced gene delivery and specificity.
- Stem cell technology presents novel platforms for targeted tumor cell modification.
- A deeper understanding of transgene function is crucial for therapeutic design.
Conclusions:
- Next-generation gene therapeutics hold promise for increased efficacy in treating brain tumors.
- Continued research in viral vectors, stem cells, and transgene mechanisms is essential.
- Gene therapy may overcome the refractoriness of brain tumors to conventional therapies.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...